Our BioTalent Social community came together for an informative discussion on ‘The Next Generation of Cell & Gene Therapies,’ hosted by our very own James Hume. The discussion touched on a multitude of topical themes and insights, including:
The role of tech-transfer offices in turning early-stage interventions into products
Current challenges and opportunities for CGT start-ups in Europe
The complexities of clinical trials, and how we can make this smoother
PHDs: the importance of scientific and entrepreneurial learning
Viral vs. non-viral vectors
Mindset in CGT: the importance of resilience, perseverance and ambiguity tolerance
Thank you to our wonderful panel members Stephen Sullivan, Kerstin Papenfuss and John Counsell for their sharp and focused insights. Take a look at the podcast